HIV Prevention and Alcohol (R01 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/25/2024
UPDATED: 03/31/2025
DUE: 05/07/2026
The NOFO seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HI...
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
$225,000
HHS-NIH11
POSTED: 11/25/2024
UPDATED: 11/25/2024
DUE: 05/07/2026
The NOFO seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HI...
Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed)
$200,000
HHS-NIH11
POSTED: 11/25/2024
UPDATED: 11/25/2024
DUE: 01/07/2026
The INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project encourages exploratory and innovative research to develop, characterize, or improve anima...
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
HHS-NIH11
POSTED: 11/24/2023
UPDATED: 01/13/2025
DUE: 11/24/2026
The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within ...
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/23/2022
UPDATED: 11/23/2022
DUE: 01/07/2026
This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Proj...
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/22/2024
UPDATED: 11/22/2024
DUE: 01/07/2028
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal dep...
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/22/2024
UPDATED: 11/22/2024
DUE: 01/07/2028
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal dep...
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/22/2024
UPDATED: 11/22/2024
DUE: 12/23/2027
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic cand...
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/22/2024
UPDATED: 11/22/2024
DUE: 12/23/2027
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic cand...
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/22/2024
UPDATED: 11/22/2024
DUE: 12/23/2027
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic cand...